慢性肢体威胁性缺血与跛行患者腔内治疗的比较
本研究基于VQI与Medicare链接数据,比较球囊扩张、支架与斑块旋切术在跛行和慢性肢体威胁性缺血(CLTI)患者中的死亡、再干预与截肢率;CLTI组斑块旋切再干预率高于球囊扩张和支架,但斑块旋切与支架的截肢率低于球囊扩张;跛行组各干预间无显著差异。
要点
- CLTI患者中,斑块旋切术后1年再干预率高于球囊扩张(HR 1.22)和支架(HR 1.27)。
- CLTI患者中,斑块旋切(HR 0.82)和支架(HR 0.76)术后1年大截肢率低于球囊扩张。
- 跛行患者中,各腔内干预的死亡、再干预和截肢率无显著差异。
核心结论
- 需进一步研究明确斑块旋切的合适适应证,因为部分CLTI患者可能在截肢率方面获益。
- 在此之前,使用斑块旋切应谨慎,因其与更高的再干预率相关。
研究设计与样本
- 本研究为对2016年10月至2019年12月期间血管外科学会国家血管质量倡议(VQI)数据与Medicare索赔数据链接的二次数据分析。
- 纳入年龄≥65岁、有跛行或CLTI症状且诊断为闭塞性疾病的患者,排除紧急或急诊干预或同期进行动脉内膜切除、旁路或双侧干预者。
- 干预分为仅球囊扩张、支架(伴或不伴球囊扩张)、斑块旋切(单独、伴或不伴支架、伴或不伴球囊扩张)。
- 采用倾向性评分匹配构建配对队列,进行死亡、再干预和截肢率的成对比较;使用多变量逻辑回归推导倾向性评分,并行Kaplan-Meier估计和Cox比例风险比(HR)(95%置信区间[CI])分析。
- 共识别9785例合格患者(跛行2665例,CLTI 7120例);CLTI组倾向性评分匹配后,球囊扩张 vs 斑块旋切、球囊扩张 vs 支架、支架 vs 斑块旋切分别使用2826、3608和2796对病例。
主要发现
- 所有干预间死亡率无统计学显著差异。
- CLTI组中,斑块旋切较球囊扩张再干预率显著升高(HR 1.22;95% CI 1.06-1.39;P = .01),较支架再干预率显著升高(HR 1.27;95% CI 1.10-1.46;P < .01),均限于索引术后第一年内。
- CLTI组中,斑块旋切(HR 0.82;95% CI 0.68-0.98;P < .05)和支架(HR 0.76;95% CI 0.64-0.90;P < .01)较球囊扩张在索引术后1年内大截肢率更低。
- 跛行组中,外周动脉疾病各干预间死亡、再干预或截肢率均无显著差异。
关键数值与推荐
- CLTI组斑块旋切 vs 球囊扩张再干预:HR 1.22(95% CI 1.06-1.39;P = .01)。
- CLTI组斑块旋切 vs 支架再干预:HR 1.27(95% CI 1.10-1.46;P < .01)。
- CLTI组斑块旋切 vs 球囊扩张大截肢:HR 0.82(95% CI 0.68-0.98;P < .05)。
- CLTI组支架 vs 球囊扩张大截肢:HR 0.76(95% CI 0.64-0.90;P < .01)。
临床怎么用
- 作者建议,在明确斑块旋切的合适适应证前,使用斑块旋切应谨慎,因其与更高的再干预率相关。
- 作者认为,部分CLTI患者可能在截肢率方面从斑块旋切中获益,需进一步研究确定。
局限性
- 需进一步研究以确定斑块旋切的合适适应证。
- 使用斑块旋切应谨慎,因其与更高的再干预率相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Analysis of regional data from the Vascular Quality Initiative (VQI) suggested improved survival for patients undergoing stent placement compared with balloon angioplasty and atherectomy. Using national data from the VQI linked to Medicare claims data through the Vascular Implant Surveillance and Interventional Outcomes Network program, this study aimed to compare the rates of mortality, reintervention, and amputation after endovascular interventions (atherectomy, stenting, and balloon angioplasty) for two separate cohorts: patients with chronic limb-threatening ischemia (CLTI) and patients with claudication. METHODS: This was a secondary data analysis of Society for Vascular Surgery National VQI data linked to Medicare claims, between October 2016 and December 2019. Patients aged ≥65 years with symptoms of claudication or CLTI and a diagnosis of occlusive disease were included. Urgent or emergent interventions or those with concurrent procedures (endarterectomy, bypass, or bilateral intervention) were excluded. Interventions were grouped into (1) balloon angioplasty only; (2) stent (with or without balloon angioplasty); or (3) atherectomy (alone, with or without stent, with or without balloon angioplasty). Propensity score-matched cohorts were constructed to conduct pairwise intervention comparisons of mortality, reintervention, and amputation rates. Multivariable logistic regression was used to derive propensity scores for each patient. Kaplan-Meier estimates and Cox proportional hazards ratios (HRs) (95% confidence interval [CI]) analyses were performed. RESULTS: A total of 9785 (2665 claudication, 7120 CLTI) eligible patients were identified. After propensity score matching for the CLTI group, 2826, 3608, and 2796 pairs of cases were used to compare balloon angioplasty vs atherectomy, balloon angioplasty vs stent, and stent vs atherectomy, respectively. No statistically significant difference in mortality was observed among all interventions. However, atherectomy was associated with a significant increase in reintervention rate compared with balloon angioplasty (HR, 1.22; 95% CI, 1.06-1.39; P = .01) and compared with stenting (HR, 1.27; 95% CI, 1.10-1.46; P < .01) within the first year after the index procedure. Of note, both atherectomy (HR, 0.82; 95% CI, 0.68-0.98; P < .05) and stenting (HR, 0.76; 95% CI, 0.64-0.90; P < .01) showed lower rates of major amputation when compared with balloon angioplasty within 1 year after the index procedure. In the claudication group, there were no significant differences observed among interventions for peripheral arterial disease for mortality, reintervention, or amputation rates. CONCLUSIONS: Further studies are needed to identify appropriate indications for atherectomy, because there may be a subset of patients with CLTI who benefit from this therapy with respect to amputation rates. Until then, caution should be exercised when using atherectomy because it is also associated with higher reintervention rates.
引用
- Chu D, Zheng X, Mao J, et al. Comparison of endovascular therapies for chronic limb-threatening ischemia and claudication. J Vasc Surg. 2023. PMID: 38070783. doi:10.1016/j.jvs.2023.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。